The Effects of Fibrinogen Concentrate Infusion on Blood Loss and Allogeneic Blood Conservation in Scoliosis Surgery
The Effects of Fibrinogen Concentrate Infusion on Perioperative Blood Loss and Allogeneic Blood Conservation in Patients Undergoing Scoliosis Surgery
Sponsor: Peking Union Medical College Hospital
Listed as NCT03183479, this PHASE4 trial focuses on Bleeding and Scoliosis; Adolescence and remains completed. Sponsored by Peking Union Medical College Hospital, it has been updated 11 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Apr 2020 — Jan 2021 [monthly]
Completed PHASE4
-
Mar 2020 — Apr 2020 [monthly]
Completed PHASE4
▶ Show 6 earlier versions
-
Jan 2020 — Mar 2020 [monthly]
Completed PHASE4
Status: Recruiting → Completed · Phase: PHASE3 → PHASE4
-
May 2019 — Jan 2020 [monthly]
Recruiting PHASE3
-
Aug 2018 — May 2019 [monthly]
Recruiting PHASE3
-
Jul 2018 — Aug 2018 [monthly]
Recruiting PHASE3
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE3
-
Jul 2017 — Jun 2018 [monthly]
Recruiting PHASE3
First recorded
Jun 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Peking Union Medical College Hospital
For direct contact, visit the study record on ClinicalTrials.gov .